1,025
Views
90
CrossRef citations to date
0
Altmetric
Critical Care

Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project

, , &
Pages 609-617 | Received 08 Apr 2015, Accepted 15 May 2015, Published online: 17 Jun 2015

References

  • EMCDDA. European Drug Report 2014: Trends and developments 2014. http://www.emcdda.europa.eu/attachements.cfm/att_228272_EN_TDAT14001ENN.pdf.
  • EMCDDA. New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015) 2015. http://www.emcdda.europa.eu/attachements.cfm/att_235958_EN_TD0415135ENN.pdf.
  • Helander A, Bäckberg M, Hulten P, Al-Saffar Y, Beck O. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Forensic Sci Int 2014; 243:23–29.
  • Helander A, Bäckberg M, Beck O. MT-45, a new psychoactive substance associated with hearing loss and unconsciousness. Clin Toxicol (Phila) 2014; 52:901–904.
  • Kronstrand R, Thelander G, Lindstedt D, Roman M, Kugelberg FC. Fatal intoxications associated with the designer opioid AH-7921. J Anal Toxicol 2014; 38:599–604.
  • Simonsen KW, Edvardsen HM, Thelander G, Ojanperä I, Thordardottir S, Andersen LV, et al. Fatal poisoning in drug addicts in the Nordic countries in 2012. Forensic Sci Int 2015; 248:172–180.
  • Stogner JM. The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl “disguised” as other opioids. Ann Emerg Med 2014; 64:637–639.
  • Janssen PA. A review of the chemical features associated with strong morphine-like activity. Br J Anaesth 1962; 34:260–268.
  • Poklis A. Fentanyl: a review for clinical and analytical toxicologists. J Toxicol Clin Toxicol 1995; 33:439–447.
  • Lane ME. The transdermal delivery of fentanyl. Eur J Pharm Biopharm 2013; 84:449–455.
  • Bowdle TA. Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. Drug Saf 1998; 19:173–189.
  • Henderson GL. Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases. J Forensic Sci 1991; 36:422–433.
  • EMCDDA. EMCDDA Trendspotter study on fentanyl in Europe. 2012. Available at: http://www.emcdda.europa.eu/attachements.cfm/att_191974_EN_TD3112230ENN_Fentanyl.pdf.
  • Tuusov J, Vals K, Tonisson M, Riikoja A, Denissov G, Vali M. Fatal poisoning in Estonia 2000–2009. Trends in illegal drug-related deaths. J Forensic Leg Med 2013; 20:51–56.
  • Vardanyan RS, Hruby VJ. Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications. Future Med Chem 2014; 6:385–412.
  • Henderson GL. Designer drugs: past history and future prospects. J Forensic Sci 1988; 33:569–575.
  • Kram TC, Cooper DA, Allen AC. Behind the identification of China White. Anal Chem 1981; 53:1379A–1386A.
  • de Boer D, Goemans WP, Ghezavat VR, van Ooijen RD, Maes RA. Seizure of illicitly produced para-fluorofentanyl: quantitative analysis of the content of capsules and tablets. J Pharm Biomed Anal 2003; 31:557–562.
  • Van Bever WF, Niemegeers CJ, Janssen PA. Synthetic analgesics. Synthesis and pharmacology of the diastereoisomers of N-(3-methyl-1-(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide and N-(3-methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl)-N-phenylpropanamide. J Med Chem 1974; 17:1047–1051.
  • Martin M, Hecker J, Clark R, Frye J, Jehle D, Lucid EJ, Harchelroad F.China White epidemic: an eastern United States emergency department experience. Ann Emerg Med 1991; 20:158–164.
  • Centers for Disease Control and Prevention. Acetyl fentanyl overdose fatalities - Rhode Island, March-May 2013. MMWR Morb Mortal Wkly Rep 2013; 62:703–704.
  • Ojanperä I, Gergov M, Liiv M, Riikoja A, Vuori E. An epidemic of fatal 3-methylfentanyl poisoning in Estonia. Int J Legal Med 2008; 122:395–400.
  • Cole JB, Dunbar JF, McIntire SA, Regelmann WE, Slusher TM. Butyrfentanyl overdose resulting in diffuse alveolar hemorrhage. Pediatrics 2015. doi: 10.1542/peds.2014–2878.
  • Higashikawa Y, Suzuki S. Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicol 2008; 26:1–5.
  • Helander A, Beck O, Hägerkvist R, Hulten P. Identification of novel psychoactive drug use in Sweden based on laboratory analysis—initial experiences from the STRIDA project. Scand J Clin Lab Invest 2013; 73:400–406.
  • Persson HE, Sjöberg GK, Haines JA, Pronczuk de Garbino J. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol 1998; 36:205–213.
  • Starmark JE, Stålhammar D, Holmgren E, Rosander B. A comparison of the Glasgow Coma Scale and the Reaction Level Scale (RLS85). J Neurosurg 1988; 69:699–706.
  • Meyer MR, Dinger J, Schwaninger AE, Wissenbach DK, Zapp J, Fritschi G, Maurer HH. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)). Anal Bioanal Chem 2012; 402:1249–1255.
  • Al-Saffar Y, Stephanson NN, Beck O. Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 930:112–120.
  • Bäckberg M, Lindeman E, Beck O, Helander A. Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clin Toxicol (Phila) 2015; 53:46–53.
  • Johansson M, Fransson D, Rundlöf T, Huynh NH, Arvidsson T. A general analytical platform and strategy in search for illegal drugs. J Pharm Biomed Anal 2014; 100:215–229.
  • Garg A, Solas DW, Takahashi LH, Cassella JV. Forced degradation of fentanyl: identification and analysis of impurities and degradants. J Pharm Biomed Anal 2010; 53:325–334.
  • McIntyre IM, Anderson DT. Postmortem fentanyl concentrations: a review. J Forensic Res 2012; 3:157.
  • Wermeling DP. Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access. Ther Adv Drug Saf 2015; 6:20–31.
  • World Health Organization. Community management of opioid overdose 2014. http://apps.who.int/iris/bitstream/10665/137462/1/9789241548816_eng.pdf?ua = 1&ua = 1.
  • Flashback.org. Butyr fentanyl. https://www.flashback.org/t1961523. (Last accessed on April, 2015)
  • Drugs-Forum.com. Butyr-fentanyl Drug Info. https://drugs-forum.com/forum/showthread.php?t = 183677. (Last accessed on April, 2015)
  • Bluelight.org. The Big and Dandy Fentanyl Analogues Thread-Acetylfentanyl/Butyrfentanyl. http://www.bluelight.org/vb/threads/615138-The-Big-and-Dandy-Fentanyl-Analogues-Thread-Acetylfentanyl-Butyrfentanyl. (Last accessed on April, 2015)
  • Baron M, Elie M, Elie L. An analysis of legal highs: do they contain what it says on the tin? Drug Test Anal 2011; 3:576–581.
  • Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, et al. Purchasing ‘legal highs’ on the Internet—is there consistency in what you get? QJM 2010; 103:489–493.
  • Zamengo L, Frison G, Bettin C, Sciarrone R. Understanding the risks associated with the use of new psychoactive substances (NPS): high variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products. Toxicol Lett 2014; 229:220–228.
  • EMCDDA. Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs 2003. http://www.emcdda.europa.eu/attachements.cfm/att_33350_EN_Risk5.pdf.
  • Vevelstad M, Oiestad EL, Middelkoop G, Hasvold I, Lilleng P, Delaveris GJ, et al. The PMMA epidemic in Norway: comparison of fatal and non-fatal intoxications. Forensic Sci Int 2012; 219:151–157.
  • Bäckberg M, Beck O, Hulten P, Rosengren-Holmberg J, Helander A. Intoxications of the new psychoactive substance 5-(2-aminopropyl)indole (5-IT): a case series from the Swedish STRIDA project. Clin Toxicol (Phila) 2014; 52:618–624.
  • Zuba D, Byrska B. Prevalence and co-existence of active components of ‘legal highs’. Drug Test Anal 2013; 5:420–429.
  • Gill JR, Lin PT, Nelson L. Reliability of postmortem fentanyl concentrations in determining the cause of death. J Med Toxicol 2013; 9:34–

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.